Non-alcoholic fatty liver disease (NAFLD) is a disorder of excessive fat accumulation in the
liver, known as steatosis, without alcohol overconsumption. NAFLD can either manifest as …

Aims To conduct a systematic literature review to identify recent epidemiological, biomarker,
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …

Non-alcoholic fatty liver disease (NAFLD) encompasses the simple steatosis to more
progressive steatosis with associated hepatitis, fibrosis, cirrhosis, and in some cases …

Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder in
the Western world. It is commonly associated with insulin resistance, obesity, dyslipidaemia …

Nonalcoholic fatty liver disease (NAFLD) is a multifactorial metabolic disorder that was first
described in 1980. It has been prevalent and on the rise for many years and is associated …

The underlying mechanism and pathogenesis of NAFLD remain elusive despite ongoing
researches to make significant advances in the understanding of its natural history …

Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease that can lead to
liver cirrhosis, liver cancer, and ultimately death. NAFLD is pathologically classified as non …

Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to nonalcoholic
steatohepatitis (NASH), leading to fibrosis and potentially cirrhosis, and it is one of the most …

Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem worldwide and an
important risk factor for both hepatic and cardiometabolic mortality. The rapidly increasing …